Stewart Robert A
Insider CIK 1476493 · CRMD Director · ACT Pres-Global Operations · AMRX President and CEO, Director · WPI Pres-Global Operations
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRMD CorMedix Inc. | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 66,453 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 36,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2023-05-17 | 2023-05-17 | 10,000 | $4.37 | $43.7K | 11,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2023-05-17 | 2023-05-18 | 10,000 | $4.37 | $43.7K | 11,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2023-04-13 | 2023-04-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2023-04-13 | 2023-04-17 | 14,200 | — | $0 | 14,200 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2019-05-07 | 2019-05-09 | 83,277 | — | $0 | 249,834 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2019-05-07 | 2019-05-09 | 21,609 | $13.44 | $290.4K | 78,668 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2019-05-07 | 2019-05-09 | 83,277 | — | $0 | 100,277 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2019-03-12 | 2019-03-12 | 17,000 | $11.92 | $202.6K | 17,000 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-03-01 | 2019-03-05 | 402,212 | — | $0 | 402,212 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-03-01 | 2019-03-05 | 197,531 | — | $0 | 197,531 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-09 | 333,111 | — | $0 | 333,111 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-09 | 681,199 | — | $0 | 681,199 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-12-29 | 2018-01-02 | 2,149 | $163.58 | $351.5K | 66,650 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-10-26 | 2017-10-30 | 12,427 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-10-26 | 2017-10-30 | 12,427 | — | $0 | 68,799 | SEC↗ |
| AGN Allergan plc | A Award | 2017-04-03 | 2017-04-04 | 7,362 | $237.68 | $1.75M | 56,372 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-03-05 | 2017-03-07 | 761 | $245.63 | $186.9K | 49,010 | SEC↗ |
| AGN Allergan plc | C Conversion deriv | 2017-02-01 | 2017-02-03 | 2,369 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-02-01 | 2017-02-03 | 798 | $229.32 | $183.0K | 49,771 | SEC↗ |
| AGN Allergan plc | A Award | 2017-02-01 | 2017-02-03 | 2,369 | $229.32 | $543.3K | 50,569 | SEC↗ |
| ACT Actavis plc | A Award | 2015-03-05 | 2015-03-09 | 4,568 | — | $0 | 48,793 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 411 | $295.70 | $121.5K | 44,225 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 593 | $295.70 | $175.4K | 48,200 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 28,245 | — | $0 | 28,245 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 25,704 | — | $0 | 25,704 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 3,383 | $197.05 | $666.6K | 44,636 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-12-09 | 2013-12-10 | 8,000 | $166.02 | $1.33M | 41,253 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-15 | 2013-11-19 | 10,000 | $164.44 | $1.64M | 49,253 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-11 | 2013-11-13 | 12,000 | $158.39 | $1.90M | 59,252 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 71,252 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 71,252 | — | $0 | 71,252 | SEC↗ |
| ACT Actavis, Inc. | D To issuer deriv | 2013-09-30 | 2013-10-02 | 75,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-09-30 | 2013-10-02 | 75,000 | $86.86 | $6.51M | 148,891 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-09-30 | 2013-10-02 | 44,312 | — | $0 | 193,203 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-30 | 2013-10-02 | 121,951 | $144.00 | $17.56M | 71,252 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-08-02 | 2013-08-06 | 14,564 | $136.02 | $1.98M | 73,891 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-02 | 2013-08-13 | 14,564 | $136.02 | $1.98M | 73,891 | SEC↗ |
| ACT Actavis, Inc. | A Award deriv | 2013-03-06 | 2013-03-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 8,844 | — | $0 | 81,164 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 7,291 | — | $0 | 88,455 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-02 | 2013-03-05 | 4,834 | $85.54 | $413.5K | 72,320 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-10-31 | 2012-11-02 | 14,543 | — | $0 | 77,154 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 10,955 | — | $0 | 54,058 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 8,553 | — | $0 | 62,611 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-02-24 | 2012-02-28 | 1,640 | $58.17 | $95.4K | 43,103 | SEC↗ |